About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Immune System Biomarker may Lead to HIV Relapse Cure

by Bidita Debnath on October 11, 2015 at 11:39 PM
Font : A-A+

 New Immune System Biomarker may Lead to HIV Relapse Cure

Thanks to the discovery of new immune system biomarker by researchers at the University of New South Wales (UNSW), Australia and the University of Oxford, scientists are now better able to predict how quickly the HIV virus will return after individuals stop treatment.

The development opens up new avenues for understanding why the HIV virus persists in some patients, and remains dormant and undetectable in others.

Advertisement

While existing anti-retroviral therapy (ART) stops the HIV virus from replicating, it does not completely remove the virus. Destroying the hidden reservoirs of the virus remains one of the holy grails of HIV research.

Led by Oxford researcher professor John Frater, the international research team analyzed data from a randomized study of patients with primary HIV infection. They compared the T-cells of 154 patients in Europe, Brazil and Australia who had their ART treatment interrupted after 12 or 48 weeks.
Advertisement

T-cells play a central role in protecting the immune system. After coming up with a shortlist of 18 immune system biomarkers, researchers discovered that three of them -- PD-1, Tim-3 and Lag-3 -- were statistically significant predictors of when the virus would rebound.

The researchers found that high levels of these biomarkers, attached to 'exhausted' T-cells prior to patients commencing ART, were associated with earlier rebound of the virus following treatment interruption.

"Focusing on the exhaustion markers was an important step as it has given us vital clues as to why some people are able to better control the virus after therapy has been interrupted," said Professor Rodney Phillips from UNSW.

Study co-author Professor Anthony Kelleher from UNSW said understanding the mechanisms that allow HIV to remain in 'remission' is essential if the virus is to be eradicated. "We want to be able to predict how the virus will behave before we take patients off ART to test drug therapies aimed at eradicating HIV," he said.

The findings were published in the journal Nature Communications.

Source: IANS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge on Lung Transplantation
Baldness can be Cured and Prevented: let us see How!
Drinking Beer or Wine Every Day Could Cause Age-related Diseases
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Oral Health And AIDS AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs Immunisation Prostitution: Fresh Stakes in the Oldest Trade 

Most Popular on Medindia

Indian Medical Journals Turmeric Powder - Health Benefits, Uses & Side Effects Hearing Loss Calculator Blood - Sugar Chart Loram (2 mg) (Lorazepam) Sinopril (2mg) (Lacidipine) Blood Pressure Calculator Pregnancy Confirmation Calculator The Essence of Yoga Nutam (400mg) (Piracetam)
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT ONLINE WITH A DOCTOR